According to Acorda Therapeutics
's latest financial reports the company has -$0.19 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $93.62 M | -38.05% |
2021-12-31 | $0.15 B | -36.49% |
2020-12-31 | $0.23 B | -23.44% |
2019-12-31 | $0.31 B | -49.21% |
2018-12-31 | $0.61 B | 17.69% |
2017-12-31 | $0.51 B | -21.71% |
2016-12-31 | $0.66 B | 10.15% |
2015-12-31 | $0.60 B | 11.62% |
2014-12-31 | $0.54 B | 22.69% |
2013-12-31 | $0.44 B | 14.1% |
2012-12-31 | $0.38 B | 88.06% |
2011-12-31 | $0.20 B | 35.67% |
2010-12-31 | $0.15 B | 10.14% |
2009-12-31 | $0.13 B | -33.71% |
2008-12-31 | $0.20 B | 226.58% |
2007-12-31 | $63.43 M | 239.78% |
2006-12-31 | $18.66 M | -116.02% |
2005-12-31 | $-0.12 B | 92.4% |
2004-12-31 | $-60.58 M | 46492.85% |
2003-12-31 | $-0.13 M | |
2003-06-30 | $35.32 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Sarepta Therapeutics
SRPT | $0.96 B | -617.41% | ๐บ๐ธ USA |
Repligen
RGEN | $1.97 B | -1,160.77% | ๐บ๐ธ USA |
Affimed
AFMD | $63.91 M | -134.40% | ๐ฉ๐ช Germany |
BioMarin Pharmaceutical BMRN | $5.07 B | -2,831.22% | ๐บ๐ธ USA |